![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
DE Murphy, J Schneider, C Boehm, J Lehmann and M Williams
3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP), a rigid analog of 2-amino-7-phosphonoheptanoic acid, has been reported as a selective N-methyl-D-aspartate (NMDA) antagonist. [3H]CPP bound with relatively high affinity (Kd = 201 nM) to Triton-treated rat brain crude synaptic membranes using a centrifugation assay. Binding was saturable, reversible, heat sensitive and dependent on protein concentration. Specific binding, which represented 75 to 85% of the total counts bound, was enriched in synaptosomal and microsomal fractions of rat brain, suggesting an involvement in events related to synaptic transmission. On a regional basis, binding was highest in hippocampus, followed by cortex greater than striatum greater than cerebellum = thalamus. No specific binding could be detected in pons medulla or in liver, kidney, heart, lung and adrenal tissue. [3H]CPP binding was stereoselective for the isomers of glutamate, 2-amino-5- phosphonopentanoic acid, homocysteic acid, alpha-aminoadipic acid and N- methyl-aspartate. The most potent compounds tested were L-glutamate and CPP, which were equiactive in displacing [3H]CPP. The order of activity of other excitatory amino acid receptor ligands was D-2-amino-5- phosphonopentanoic acid greater than L-homocysteic acid greater than or equal to DL-2-amino-7-phosphonoheptanoic acid = D-aspartate = L- aspartate greater than L-serine-O-sulfate = D-alpha-aminoadipic acid = ibotenate greater than NMDA greater than DL-2-amino-6-phosphonohexanoic acid greater than quisqualate greater than N-methyl-L-aspartate. The quisqualate- and kainate-type receptor agonists DL-alpha-amino-3- hydroxy-5-methylisoxazole-4-propionate and kainic acid, respectively, had negligible activity at 100 microM.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  L. Sun, D. Chiu, D. Kowal, R. Simon, M. Smeyne, R. S. Zukin, J. Olney, R. Baudy, and S. Lin Characterization of Two Novel N-Methyl-D-aspartate Antagonists: EAA-090 (2-[8,9-Dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en2-yl]ethylphosphonic Acid) and EAB-318 (R-{alpha}-Amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic Acid Hydrochloride) J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 563 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Paveto, C. Pereira, J. Espinosa, A. E. Montagna, M. Farber, Món. Esteva, M. M. Flawiá, and Héc. N. Torres The Nitric Oxide Transduction Pathway in Trypanosoma cruzi J. Biol. Chem., July 14, 1995; 270(28): 16576 - 16579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Faden, P Demediuk, S. Panter, and R Vink The role of excitatory amino acids and NMDA receptors in traumatic brain injury Science, May 19, 1989; 244(4906): 798 - 800. [Abstract] [PDF]
|
|
|
|
|
|
J. M. McIntosh, G. O. Corpuz, R. T. Layer, J. E. Garrett, J. D. Wagstaff, G. Bulaj, A. Vyazovkina, D. Yoshikami, L. J. Cruz, and B. M. Olivera Isolation and Characterization of a Novel Conus Peptide with Apparent Antinociceptive Activity J. Biol. Chem., October 13, 2000; 275(42): 32391 - 32397. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
